Reference
Shan W, et al. Adverse events in lymphoma patients treated with phosphoinositide 3 kinase Inhibitor in clinical trials: a meta-analysis Annals of Hematology : 13 Jun 2022. Available from: URL: https://doi.org/10.1007/s00277-022-04876-x
Rights and permissions
About this article
Cite this article
AEs of phosphoinositide 3 kinase Inhibitors in patients with lymphoma. Reactions Weekly 1911, 6 (2022). https://doi.org/10.1007/s40278-022-17303-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-17303-z